Genesis BioCapital
Actively deployingChattanooga
Investment thesis
Genesis BioCapital focuses on creating and investing in the future of medicine, supporting innovative medical ventures and biotechnology companies.
Source: firm website, verified Jul 21, 2026.
Frequently asked questions
- What sectors does Genesis BioCapital focus on?
- Genesis BioCapital focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is Genesis BioCapital located?
- Genesis BioCapital is headquartered in Chattanooga, US.
Similar investors
B Capital is a venture capital firm managing over $12 billion in assets with a stage-based fund approach. The firm invests across early to late-stage companies in technology, healthcare, and energy & resilience sectors, with 200+ portfolio companies and 9 global offices.
Breyer Capital is a venture capital firm that invests in high-impact entrepreneurs with a strategic focus on companies leveraging artificial intelligence and machine learning to transform technology sectors globally.
DCVC is a deep tech venture capital firm with over a dozen years of experience backing entrepreneurs using computational approaches to solve trillion-dollar problems across industries including AI, climate, materials science, robotics, space, and biology.
GV is Alphabet's venture capital arm, established in 2009 as Google Ventures. Operating with long time horizons and over $13 billion in assets under management, the firm invests across technology and life sciences sectors from seed to growth stages, supporting 400 active portfolio companies across North America, Europe, and Israel.
Innovestor is a Finnish investment manager that operates across venture capital, real estate, and energy storage sectors. The firm invests in early-stage technology and life science startups, energy-efficient commercial real estate, and battery storage and solar solutions. Innovestor also provides corporate venturing advisory services.